Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4255398 Title: PRÉPARATION ADMINISTRÉE PAR VOIE ORALE CONTENANT DE LA SOLIFÉNACINE ET DE LA TAMSULOSINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
218198778
WO application number:
EP2021083654
Type:
European patent granted for BE
Status:
Open
Publication number:
4255398
WO publication number:
WO2022117594
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/11/2021
Grant date:
07/08/2024
EP publication date:
11/10/2023
WO publication date:
09/06/2022
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
07/08/2024
EP B1 publication date:
07/08/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/11/2041

Applicant

1

Name:
Adamed Pharma S.A.
Legal Form:
From:
07/08/2024
Address:
Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow, Poland (PL)
To:

2

Name:
Adalvo Limited
Legal Form:
From:
07/08/2024
Address:
Malta Life Science Park Building 1 Level 4, San Gwann, SGN 3000, Malta (MT)
To:

Inventor

Name:
BOLTROMIUK, Tomasz
Legal Form:
Address:
02-496 Warszawa, Poland (PL)

Priority

Priority patent number:
20211022
Priority date:
01/12/2020
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/20;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/15
Publication date:
29/08/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202432
Publication date:
07/08/2024
Description:
Grant (B1)

2

Issue number:
202436
Publication date:
04/09/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
02/06/2025
Annual fee number:
4
Annual fee amount:
55 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type